Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiovascular risk and biomarkers in renal transplant recipients treated with belatacept versus calcineurin inhibitors
2013-001178-20Phase 4Completed
- Sponsor
- Akademiska sjukhuset
- Start
- Sep 2013
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of belatacept in kidney transplant immunosuppression (2 arms), sponsored by Akademiska sjukhuset. Started Sep 2013; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplant immunosuppression
Beyond the preview
Go deeper on 2013-001178-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-001178-20.